OBJECTIVES: To determine if soluble CD40 ligand (sCD40L; formally CD154) levels vary with age and to identify age-dependent ranges in healthy pediatric and adult populations. STUDY DESIGN: sCD40L was measured in 25 neonates, 74 children (3 months-15 years of age) and 20 adults using an enzyme-linked immunosorbent assay. For age group comparisons, Mann-Whitney tests were performed. Correlation coefficients assessed relationships between plasma and serum sCD40L. RESULTS: Plasma sCD40L levels were higher in neonates than in all other age groups, (P <.001). All grouped pediatric plasma levels were significantly higher than in adults (P < .0001). There were no significant differences in plasma sCD40L between pediatric age groups. Serum levels were significantly higher in neonates than in any other age group (P < .0001). Pediatric and adult serum sCD40L levels were not significantly different. CONCLUSIONS: Plasma sCD40L levels are highest at birth and remain higher than those in adults throughout childhood. Reasons for such developmental changes remain to be investigated. Age-appropriate reference ranges should be used when sCD40L is being evaluated in pediatric disorders.
OBJECTIVES: To determine if soluble CD40 ligand (sCD40L; formally CD154) levels vary with age and to identify age-dependent ranges in healthy pediatric and adult populations. STUDY DESIGN: sCD40L was measured in 25 neonates, 74 children (3 months-15 years of age) and 20 adults using an enzyme-linked immunosorbent assay. For age group comparisons, Mann-Whitney tests were performed. Correlation coefficients assessed relationships between plasma and serum sCD40L. RESULTS: Plasma sCD40L levels were higher in neonates than in all other age groups, (P <.001). All grouped pediatric plasma levels were significantly higher than in adults (P < .0001). There were no significant differences in plasma sCD40L between pediatric age groups. Serum levels were significantly higher in neonates than in any other age group (P < .0001). Pediatric and adult serum sCD40L levels were not significantly different. CONCLUSIONS: Plasma sCD40L levels are highest at birth and remain higher than those in adults throughout childhood. Reasons for such developmental changes remain to be investigated. Age-appropriate reference ranges should be used when sCD40L is being evaluated in pediatric disorders.
Authors: C D Garlichs; S Eskafi; D Raaz; A Schmidt; J Ludwig; M Herrmann; L Klinghammer; W G Daniel; A Schmeisser Journal: Heart Date: 2001-12 Impact factor: 5.994
Authors: N Tamura; S Kobayashi; K Kato; H Bando; K Haruta; M Oyanagi; M Kuriyama; T J Kipps; H Hashimoto Journal: J Rheumatol Date: 2001-12 Impact factor: 4.666
Authors: Patrick André; K S Srinivasa Prasad; Cécile V Denis; Ming He; Jessie M Papalia; Richard O Hynes; David R Phillips; Denisa D Wagner Journal: Nat Med Date: 2002-03 Impact factor: 53.440
Authors: Lisa Nannizzi-Alaimo; Mark H Rubenstein; Veronica L Alves; Gil Y Leong; David R Phillips; Herman K Gold Journal: Circulation Date: 2002-06-18 Impact factor: 29.690
Authors: S L Spinelli; J J O'Brien; S Bancos; G M Lehmann; D L Springer; N Blumberg; C W Francis; M B Taubman; R P Phipps Journal: PPAR Res Date: 2008 Impact factor: 4.964